These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6982860)
1. Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant. Mak NK; Zhang YH; Ada GL; Tannock GA Infect Immun; 1982 Oct; 38(1):218-25. PubMed ID: 6982860 [TBL] [Abstract][Full Text] [Related]
2. Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune response to two H1N1 and H3N2 viruses. Tao SJ; Mak NK; Ada GL J Virol; 1985 Feb; 53(2):645-50. PubMed ID: 3871484 [TBL] [Abstract][Full Text] [Related]
3. The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses. Mak NK; Sweet C; Ada GL; Tannock GA Immunology; 1984 Feb; 51(2):407-16. PubMed ID: 6319274 [TBL] [Abstract][Full Text] [Related]
4. Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum. Mak NK; Schiltknecht E; Ada GL Cell Immunol; 1983 Jun; 78(2):314-25. PubMed ID: 6861206 [TBL] [Abstract][Full Text] [Related]
5. In vivo effects of cyclosporine on influenza A virus-infected mice. Schiltknecht E; Ada GL Cell Immunol; 1985 Mar; 91(1):227-39. PubMed ID: 2982505 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains. Wareing MD; Harrison LC; Tannock GA Vaccine; 2005 Jul; 23(31):4075-81. PubMed ID: 15963362 [TBL] [Abstract][Full Text] [Related]
7. [Changes in natural killer activity in the influenza virus infection of mice and in treating lymphocytes with the influenza virus and its proteins in vitro]. Trushinskaia GN; Gubareva LV; Parasiuk NA; Ivanova VT; Zhadanov VM Vopr Virusol; 1988; 33(1):11-7. PubMed ID: 3259351 [TBL] [Abstract][Full Text] [Related]
8. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125 [TBL] [Abstract][Full Text] [Related]
9. Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Murphy BR; Holley HP; Berquist EJ; Levine MM; Spring SB; Maassab HF; Kendal AP; Chanock RM Infect Immun; 1979 Feb; 23(2):253-9. PubMed ID: 422240 [TBL] [Abstract][Full Text] [Related]
10. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
11. Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Bender BS; Johnson MP; Small PA Immunology; 1991 Apr; 72(4):514-9. PubMed ID: 2037313 [TBL] [Abstract][Full Text] [Related]
12. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
13. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Tannock GA; Paul JA; Barry RD Infect Immun; 1984 Feb; 43(2):457-62. PubMed ID: 6693167 [TBL] [Abstract][Full Text] [Related]
14. The IgG subclass responses induced by wild-type, cold-adapted and purified haemagglutinin from influenza virus A/Queensland/6/72 in CBA/CaH mice. Hocart MJ; Mackenzie JS; Stewart GA J Gen Virol; 1988 Aug; 69 ( Pt 8)():1873-82. PubMed ID: 2841404 [TBL] [Abstract][Full Text] [Related]
15. Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. Burger RA; Billingsley JL; Huffman JH; Bailey KW; Kim CU; Sidwell RW Immunopharmacology; 2000 Apr; 47(1):45-52. PubMed ID: 10708809 [TBL] [Abstract][Full Text] [Related]
16. Modification of cytotoxic T-cell response patterns by administration of hemagglutinin-specific monoclonal antibodies to mice infected with influenza A viruses. Greenspan N; Doherty PC Hybridoma; 1982; 1(2):149-59. PubMed ID: 6092263 [TBL] [Abstract][Full Text] [Related]
17. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice. Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854 [TBL] [Abstract][Full Text] [Related]
18. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. Scherle PA; Palladino G; Gerhard W J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795 [TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus. Santoro MG; Favalli C; Mastino A; Jaffe BM; Esteban M; Garaci E Arch Virol; 1988; 99(1-2):89-100. PubMed ID: 3355375 [TBL] [Abstract][Full Text] [Related]
20. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. Hamilton-Easton A; Eichelberger M J Virol; 1995 Oct; 69(10):6359-66. PubMed ID: 7666537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]